FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 84 filers reported holding FORTRESS BIOTECH INC in Q4 2021. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,586 | -47.2% | 12,350 | 0.0% | 0.00% | – |
| Q2 2023 | $6,793 | -32.9% | 12,350 | 0.0% | 0.00% | – |
| Q1 2023 | $10,127 | +22.1% | 12,350 | 0.0% | 0.00% | – |
| Q4 2022 | $8,295 | -65.4% | 12,350 | -56.2% | 0.00% | – |
| Q3 2022 | $24,000 | +33.3% | 28,201 | +28.4% | 0.00% | – |
| Q2 2022 | $18,000 | -33.3% | 21,959 | +9.7% | 0.00% | – |
| Q1 2022 | $27,000 | +12.5% | 20,020 | +113.0% | 0.00% | – |
| Q4 2021 | $24,000 | +166.7% | 9,400 | +235.7% | 0.00% | – |
| Q3 2021 | $9,000 | -30.8% | 2,800 | -26.3% | 0.00% | – |
| Q2 2021 | $13,000 | -48.0% | 3,800 | -45.7% | 0.00% | – |
| Q1 2021 | $25,000 | +13.6% | 7,000 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | -77.1% | 7,000 | -70.7% | 0.00% | – |
| Q3 2020 | $96,000 | +209.7% | 23,878 | +101.0% | 0.00% | – |
| Q2 2020 | $31,000 | +416.7% | 11,878 | +293.8% | 0.00% | – |
| Q1 2020 | $6,000 | – | 3,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |